Skip to main content
Erschienen in: Journal of Neurology 9/2012

01.09.2012 | Original Article

Inpatient treatment of functional motor symptoms: a long-term follow-up study

verfasst von: T. A. Saifee, P. Kassavetis, I. Pareés, M. Kojovic, L. Fisher, L. Morton, J. Foong, G. Price, E. M. Joyce, M. J. Edwards

Erschienen in: Journal of Neurology | Ausgabe 9/2012

Einloggen, um Zugang zu erhalten

Abstract

Functional neurological disorders are common, disabling and often difficult to treat. There is little consensus on the best approach to management. Multidisciplinary inpatient approaches are employed in some centres for patients with severe refractory symptoms, but their efficacy and, in particular, long-term outcomes are uncertain. We conducted a study using questionnaires completed retrospectively by patients treated at a specialised multidisciplinary inpatient programme at the National Hospital for Neurology and Neurosurgery. Consecutive patients with functional motor symptoms admitted to this centre between 2006 and 2008 were invited to participate. Questionnaires were sent at least 2 years after discharge. We contacted 32 patients, and 26 responded. The majority had symptoms for at least 3 years prior to admission; 58 % of patients reported benefit from the programme on discharge. This self-reported benefit to symptoms and function was after a 2-year follow-up period in the majority of patients, but return to work or cessation of health-related financial benefits was uncommon even in those who improved. Seventy-four percent of those questioned stated they would recommend the programme to others with similar symptoms. Attribution of symptoms to stress or emotional state was correlated with favourable outcome. Our data suggest that multidisciplinary inpatient treatment for patients with refractory functional motor symptoms provides self-reported benefit in the long-term. Prospective analysis of such interventions and the determinants of benefit need assessment in order to improve the service and target treatment to patients most likely to benefit.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Cella M, Sharpe M, Chalder T (2011) Measuring disability in patients with chronic fatigue syndrome: reliability and validity of the work and social adjustment scale. J Psychosom Res 71:124–128PubMedCrossRef Cella M, Sharpe M, Chalder T (2011) Measuring disability in patients with chronic fatigue syndrome: reliability and validity of the work and social adjustment scale. J Psychosom Res 71:124–128PubMedCrossRef
2.
Zurück zum Zitat Czarnecki K, Thompson JM, Seime R, Geda YE, Duffy JR, Ahlskog JE (2011) Functional movement disorders: successful treatment with a physical therapy rehabilitation protocol. Parkinsonism Relat Disord 38:311–316 Czarnecki K, Thompson JM, Seime R, Geda YE, Duffy JR, Ahlskog JE (2011) Functional movement disorders: successful treatment with a physical therapy rehabilitation protocol. Parkinsonism Relat Disord 38:311–316
3.
4.
Zurück zum Zitat Hammer A, Mohammadi B, Schmicker M, Saliger S, Münte TF (2011) Errorless and errorful learning modulated by transcranial direct current stimulation. BMC Neurosci 12:72PubMedCrossRef Hammer A, Mohammadi B, Schmicker M, Saliger S, Münte TF (2011) Errorless and errorful learning modulated by transcranial direct current stimulation. BMC Neurosci 12:72PubMedCrossRef
5.
Zurück zum Zitat Jankovic J, Cloninger CR, Fahn S, Hallett M, Lang AE, Williams DT (2005) Therapeutic approaches to psychogenic movement disorders. In: Hallett M, Fahn S, Jankovic J, Lang AE, Cloninger CR, Yudofsky SC (eds) Psychogenic movement disorders: neurology and neuropsychiatry (board review series). Lippincott Williams and Wilkins, USA, pp 323–328 Jankovic J, Cloninger CR, Fahn S, Hallett M, Lang AE, Williams DT (2005) Therapeutic approaches to psychogenic movement disorders. In: Hallett M, Fahn S, Jankovic J, Lang AE, Cloninger CR, Yudofsky SC (eds) Psychogenic movement disorders: neurology and neuropsychiatry (board review series). Lippincott Williams and Wilkins, USA, pp 323–328
6.
Zurück zum Zitat Kroenke K (2007) Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med 69:881–888PubMedCrossRef Kroenke K (2007) Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med 69:881–888PubMedCrossRef
7.
Zurück zum Zitat Kuyk J, Siffels MC, Bakvis P, Swinkels WA (2008) Psychological treatment of patients with psychogenic non-epileptic seizures: an outcome study. Seizure 17:595–603PubMedCrossRef Kuyk J, Siffels MC, Bakvis P, Swinkels WA (2008) Psychological treatment of patients with psychogenic non-epileptic seizures: an outcome study. Seizure 17:595–603PubMedCrossRef
8.
Zurück zum Zitat Lang AE, Voon V (2011) Psychogenic movement disorders: past developments, current status, and future directions. Mov Disord 26:1175–1186PubMedCrossRef Lang AE, Voon V (2011) Psychogenic movement disorders: past developments, current status, and future directions. Mov Disord 26:1175–1186PubMedCrossRef
9.
Zurück zum Zitat McKenzie P, Oto M, Russell A, Pelosi A, Duncan R (2010) Early outcomes and predictors in 260 patients with psychogenic nonepileptic attacks. Neurology 74:64–69PubMedCrossRef McKenzie P, Oto M, Russell A, Pelosi A, Duncan R (2010) Early outcomes and predictors in 260 patients with psychogenic nonepileptic attacks. Neurology 74:64–69PubMedCrossRef
10.
Zurück zum Zitat Moss-Morris R, Weinman J, Petrie KJ, Horne R, Cameron LD, Buick D (2002) The revised illness perception questionnaire (IPQ-R). Psychol Health 17:1–16CrossRef Moss-Morris R, Weinman J, Petrie KJ, Horne R, Cameron LD, Buick D (2002) The revised illness perception questionnaire (IPQ-R). Psychol Health 17:1–16CrossRef
11.
Zurück zum Zitat Parees I, Saifee TA, Kassavetis P, Kojovic M, Rubio-Agusti I, Rothwell JC, Bhatia KP, Edwards MJ (2011) Believing is perceiving: mismatch between self-report and actigraphy in psychogenic tremor. Brain 135(1):117–123PubMedCrossRef Parees I, Saifee TA, Kassavetis P, Kojovic M, Rubio-Agusti I, Rothwell JC, Bhatia KP, Edwards MJ (2011) Believing is perceiving: mismatch between self-report and actigraphy in psychogenic tremor. Brain 135(1):117–123PubMedCrossRef
12.
Zurück zum Zitat Peters S, Stanley I, Rose M, Kaney S, Salmon P (2002) A randomized controlled trial of group aerobic exercise in primary care patients with persistent, unexplained physical symptoms. Fam Pract 19:665–674PubMedCrossRef Peters S, Stanley I, Rose M, Kaney S, Salmon P (2002) A randomized controlled trial of group aerobic exercise in primary care patients with persistent, unexplained physical symptoms. Fam Pract 19:665–674PubMedCrossRef
13.
Zurück zum Zitat Sharpe M, Stone J, Hibberd C, Warlow C, Duncan R, Coleman R, Roberts R, Cull R, Pelosi A, Cavanagh J, Matthews K, Goldbeck R, Smyth R, Walker A, Walker J, MacMahon A, Murray G, Carson A (2010) Neurology out-patients with symptoms unexplained by disease: illness beliefs and financial benefits predict 1 year outcome. Psychol Med 40:689–698PubMedCrossRef Sharpe M, Stone J, Hibberd C, Warlow C, Duncan R, Coleman R, Roberts R, Cull R, Pelosi A, Cavanagh J, Matthews K, Goldbeck R, Smyth R, Walker A, Walker J, MacMahon A, Murray G, Carson A (2010) Neurology out-patients with symptoms unexplained by disease: illness beliefs and financial benefits predict 1 year outcome. Psychol Med 40:689–698PubMedCrossRef
14.
Zurück zum Zitat Sharpe M, Walker J, Williams C, Stone J, Cavanagh J, Murray G, Butcher I, Duncan R, Smith S, Carson A (2011) Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial. Neurology 77:564–572PubMedCrossRef Sharpe M, Walker J, Williams C, Stone J, Cavanagh J, Murray G, Butcher I, Duncan R, Smith S, Carson A (2011) Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial. Neurology 77:564–572PubMedCrossRef
15.
Zurück zum Zitat Stone J, Carson A, Duncan R, Roberts R, Warlow C, Hibberd C, Coleman R, Cull R, Murray G, Pelosi A, Cavanagh J, Matthews K, Goldbeck R, Smyth R, Walker J, Sharpe M (2010) Who is referred to neurology clinics? The diagnoses made in 3781 new patients. Clin Neurol Neurosurg 112:747–751PubMedCrossRef Stone J, Carson A, Duncan R, Roberts R, Warlow C, Hibberd C, Coleman R, Cull R, Murray G, Pelosi A, Cavanagh J, Matthews K, Goldbeck R, Smyth R, Walker J, Sharpe M (2010) Who is referred to neurology clinics? The diagnoses made in 3781 new patients. Clin Neurol Neurosurg 112:747–751PubMedCrossRef
16.
Zurück zum Zitat Thomas M, Vuong KD, Jankovic J (2006) Long-term prognosis of patients with psychogenic movement disorders. Parkinsonism Relat Disord 12(6):382–387PubMedCrossRef Thomas M, Vuong KD, Jankovic J (2006) Long-term prognosis of patients with psychogenic movement disorders. Parkinsonism Relat Disord 12(6):382–387PubMedCrossRef
17.
Zurück zum Zitat Voon V, Lang AE (2005) Antidepressant treatment outcomes of psychogenic movement disorder. J Clin Psychiatry 66:1529–1534PubMedCrossRef Voon V, Lang AE (2005) Antidepressant treatment outcomes of psychogenic movement disorder. J Clin Psychiatry 66:1529–1534PubMedCrossRef
Metadaten
Titel
Inpatient treatment of functional motor symptoms: a long-term follow-up study
verfasst von
T. A. Saifee
P. Kassavetis
I. Pareés
M. Kojovic
L. Fisher
L. Morton
J. Foong
G. Price
E. M. Joyce
M. J. Edwards
Publikationsdatum
01.09.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 9/2012
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-012-6530-6

Weitere Artikel der Ausgabe 9/2012

Journal of Neurology 9/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.